Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO
Shareholders who purchased shares of MREO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.
CLASS PERIOD:
DEADLINE:
CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. Mereo misled investors about its Phase 3 ORBIT and COSMIC programs. Both programs failed to achieve their endpoints against placebo or bisphosphonate control groups, respectively. Based on these facts, Mereo's public statements were false and materially misleading throughout the class period.
If you are a shareholder who suffered a loss, contact us to participate.
WHY DJS LAW GROUP?
Join the case to recover your losses.
This press release may be considered
CONTACT:
Eastchester, NY 10709
Phone: 914-206-9742
Email: David@djslawllp.com
View original content:https://www.prnewswire.com/news-releases/mereo-biopharma-group-plc-sued-for-securities-law-violations---contact-the-djs-law-group-to-discuss-your-rights--mreo-302711857.html
SOURCE